Erlotinib is used to treat metastatic non-small cell lung cancer, as first line treatment, maintenance treatment, or after failure of one prior chemotherapy. It is also used to treat locally advanced, unresectable (which cannot be removed by surgery), or metastatic (cancer which has spread) pancreatic cancer in combination with another drug called gemcitabine.
| BRAND NAME | MANUFACTURER |
| TYROKININ | Dr Reddy’s Laboratories Ltd |
| ERLEVA | Glenmark Pharmaceuticals Ltd |
| ERLOCIP | Cipla Ltd |
| TARCEVA | Roche Products India Pvt Ltd |
| LORTINIB | RPG Life Sciences Ltd |
| ERLOCIP | Cipla Ltd |
| ERLOSTAR | Lupin Ltd |
| ERLOTIB | Intas Pharmaceuticals Ltd |
Everolimus 
